Novak Rodger

CIK 00016820171 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001682017

Recent Transactions

50 trades

Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-06-30$165.00/sh−25,000→ 573,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-06-28$156.55/sh−25,000→ 598,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-06-21$125.58/sh−1,171→ 646,836 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-06-21$129.46/sh−7,299→ 623,057 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-06-21$127.71/sh−2,969→ 642,986 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-06-21$126.62/sh−881→ 645,955 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-06-21$130.27/sh−50→ 623,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2021-06-21$128.76/sh−12,630→ 630,356 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-11-30$14.00/sh+50,000→ 698,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-11-30$125.00/sh−50,000→ 648,007 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-11-30−50,000→ 61,893 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-11-30$125.00/sh−50,000→ 648,007 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-11-30−50,000→ 140,315 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-11-30$14.43/sh+50,000→ 698,007 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-10-09$14.43/sh+2,762→ 650,769 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-10-09$100.00/sh−2,762→ 648,007 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-10-09−2,762→ 190,315 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-10-08$100.00/sh−22,238→ 648,007 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-10-08$14.43/sh+22,238→ 670,245 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-10-08−22,238→ 193,077 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-09-01$14.00/sh+3,933→ 651,940 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-09-01$92.59/sh−19,754→ 651,847 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-09-01−3,933→ 111,893 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-09-01$14.43/sh+21,067→ 673,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-09-01$91.54/sh−1,406→ 671,601 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-09-01$93.19/sh−3,840→ 648,007 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-09-01−21,067→ 215,315 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-08-19$100.00/sh−25,000→ 648,007 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-08-19−25,000→ 115,826 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-08-19$14.00/sh+25,000→ 673,007 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-07-07−5,586→ 0 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-07-07$14.00/sh+19,414→ 673,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-07-07$90.00/sh−25,000→ 648,007 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-07-07$1.81/sh+5,586→ 653,593 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-07-07−19,414→ 140,826 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-07-01$80.00/sh−50,000→ 648,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-06-23$75.00/sh−50,000→ 698,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-05-26$70.27/sh−36,616→ 748,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-05-22$70.01/sh−13,384→ 784,623 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-05-19$65.00/sh−50,000→ 798,007 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2019-11-19−33,618→ 236,382 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2019-11-19$14.43/sh+33,618→ 33,618 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-11-19$70.00/sh−33,618→ 0 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-07-10$50.00/sh−50,000→ 848,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-06-10$45.00/sh−50,000→ 898,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-03-04$42.03/sh−3,500→ 948,007 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-03-04$41.29/sh−8,912→ 951,507 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-03-04$40.24/sh−64,115→ 960,419 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-03-01$40.01/sh−8,693→ 1,024,534 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2019-02-25$40.00/sh−14,780→ 1,033,227 total

Companies

CRISPR Therapeutics AG
Director, Chief Executive Officer
$CRSP

Recent Filings

Address

C/O CRISPR THERAPEUTICS, INC. 200 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov